Jazz Pharmaceuticals
JAZZ
#1815
Rank
A$15.71 B
Marketcap
A$255.30
Share price
-0.36%
Change (1 day)
16.20%
Change (1 year)

Market capitalization of Jazz Pharmaceuticals (JAZZ)

Market cap: A$15.71 Billion

As of March 2026 Jazz Pharmaceuticals has a market cap of A$15.71 Billion. This makes Jazz Pharmaceuticals the world's 1815th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Jazz Pharmaceuticals from 2007 to 2026

End of year Market Cap

Year Marketcap Change
2026A$15.71 B1.62%
2025A$15.46 B27.71%
2024A$12.11 B6.55%
2023A$11.36 B-22.89%
2022A$14.74 B36.46%
2021A$10.80 B-10.41%
2020A$12.05 B0.73%
2019A$11.96 B18.3%
2018A$10.11 B-2.14%
2017A$10.33 B14.14%
2016A$9.05 B-23.41%
2015A$11.82 B-2.5%
2014A$12.13 B47.8%
2013A$8.20 B176.13%
2012A$2.97 B87.17%
2011A$1.58 B105.16%
2010A$0.77 B182.37%
2009A$0.27 B308.24%
2008A$67.16 M-83.73%
2007A$0.41 B

End of Day market cap according to different sources

On Mar 17th, 2026 the market cap of Jazz Pharmaceuticals was reported to be:

A$15.71 Billion
by Nasdaq info icon info icon
A$15.71 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Novartis
NVS
A$421.34 B 2,580.97%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AmerisourceBergen
ABC
A$50.88 B 223.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
A$0.19 M-100.00%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Teva Pharmaceutical Industries
TEVA
A$49.32 B 213.87%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel